These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

68 related items for PubMed ID: 2206227

  • 1. Renal allograft immunosuppression. I. Early inflammatory and rejection episodes in triple drug treatment compared to double drug combinations or cyclosporin monotherapy.
    Isoniemi H, Ahonen J, Eklund B, Höckerstedt K, Salmela K, von Willebrand E, Häyry P.
    Transpl Int; 1990 Jul; 3(2):92-7. PubMed ID: 2206227
    [Abstract] [Full Text] [Related]

  • 2. Renal allograft immunosuppression. II. A randomized trial of withdrawal of one drug in triple drug immunosuppression.
    Isoniemi H, Ahonen J, Eklund B, Höckerstedt K, Salmela K, von Willebrand E, Häyry P.
    Transpl Int; 1990 Oct; 3(3):121-7. PubMed ID: 2271083
    [Abstract] [Full Text] [Related]

  • 3. Renal allograft immunosuppression. IV. Comparison of lipid and lipoprotein profiles in blood using double and triple immunosuppressive drug combinations.
    Isoniemi H, Tikkanen MJ, Ahonen J, Häyry P.
    Transpl Int; 1991 Sep; 4(3):130-5. PubMed ID: 1958276
    [Abstract] [Full Text] [Related]

  • 4. Effects of cyclosporine, azathioprine, and steroids on the renal transplant, on the cytologic patterns of intragraft inflammation, and on concomitant rejection-associated changes in recipient blood.
    Häyry P, von Willebrand E, Ahonen J, Eklund B, Salmela K, Höckerstedt K, Pettersson E, Koskimies S.
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):153-62. PubMed ID: 3284065
    [Abstract] [Full Text] [Related]

  • 5. Long-term outcome after switch from cyclosporine-based triple-drug immunosuppression to double therapy at three months.
    Aichberger C, Eberl T, Riedmann B, Pernthaler H, Ofner D, Königsrainer A, Margreiter R.
    Clin Transplant; 1996 Apr; 10(2):209-12. PubMed ID: 8664521
    [Abstract] [Full Text] [Related]

  • 6. Renal allograft immunosuppression. VI. Triple drug therapy versus immunosuppressive double drug combinations: histopathological findings in renal allografts.
    Isoniemi H, Krogerus L, von Willebrand E, Taskinen E, Grönhagen-Riska C, Ahonen J, Häyry P.
    Transpl Int; 1991 Sep; 4(3):151-6. PubMed ID: 1958279
    [Abstract] [Full Text] [Related]

  • 7. Annual trends and triple therapy--1991-2000.
    Nishikawa K, Terasaki PI.
    Clin Transpl; 2001 Sep; ():247-69. PubMed ID: 12211788
    [Abstract] [Full Text] [Related]

  • 8. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
    Shabtai M, Ben-Haim M, Zemer D, Malinger-Saavedra P, Rosin D, Kuriansky J, Lustig S, Shabtai EL, Shapira Z, Ayalon A.
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
    [Abstract] [Full Text] [Related]

  • 9. Immunosuppression in live-related donor renal transplantation.
    Iman A, Rao M, Juneja R, Jacob CK.
    Natl Med J India; 2001 Nov; 14(2):75-80. PubMed ID: 11396322
    [Abstract] [Full Text] [Related]

  • 10. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis.
    Bemelman FJ, de Maar EF, Press RR, van Kan HJ, ten Berge IJ, Homan van der Heide JJ, de Fijter HW.
    Transplantation; 2009 Aug 15; 88(3):421-8. PubMed ID: 19667948
    [Abstract] [Full Text] [Related]

  • 11. Renal transplantation at Hartford Hospital: results of combined and flexible immunosuppression.
    Schweizer RT, Bow L, Roper L, Hull D, Bartus SA.
    Clin Transpl; 1988 Aug 15; ():147-58. PubMed ID: 3154467
    [Abstract] [Full Text] [Related]

  • 12. A prospective randomized trial of pretransfusion/azathioprine/prednisone versus cyclosporine/prednisone immunosuppression in cardiac transplant recipients: preliminary results.
    Barnhart GR, Hastillo A, Goldman MH, Szentpetery S, Wolfgang TC, Mohanakumar T, Katz MR, Rider S, Hanrahan J, Lower RR.
    Circulation; 1985 Sep 15; 72(3 Pt 2):II227-30. PubMed ID: 3896555
    [Abstract] [Full Text] [Related]

  • 13. [Results, over a 3-year, period of a triple combination: cyclosporin, azathioprine, prednisolone in high-risk kidney transplants].
    Hiesse C, Rieu P, Neyrat N, Charpentier B, Benoit G, Bellamy J, Fries D.
    Nephrologie; 1987 Sep 15; 8(3):127-9. PubMed ID: 3309700
    [Abstract] [Full Text] [Related]

  • 14. Effect of cyclosporin A on DNA repair and cancer incidence in kidney transplant recipients.
    Herman M, Weinstein T, Korzets A, Chagnac A, Ori Y, Zevin D, Malachi T, Gafter U.
    J Lab Clin Med; 2001 Jan 15; 137(1):14-20. PubMed ID: 11150019
    [Abstract] [Full Text] [Related]

  • 15. Independent risk factors predicting acute graft rejection in cardiac transplant recipients treated by triple drug immunosuppression.
    Laufer G, Miholic J, Laczkovics A, Wollenek G, Holzinger C, Hajek-Rosenmeier A, Wuzl G, Schreiner W, Buxbaum P, Wolner E.
    J Thorac Cardiovasc Surg; 1989 Dec 15; 98(6):1113-21. PubMed ID: 2586129
    [Abstract] [Full Text] [Related]

  • 16. Rejection rates in a randomised trial of tacrolimus monotherapy versus triple therapy in liver transplant recipients with hepatitis C virus cirrhosis.
    Samonakis DN, Mela M, Quaglia A, Triantos CK, Thalheimer U, Leandro G, Pesci A, Raimondo ML, Dhillon AP, Rolles K, Davidson BR, Patch DW, Burroughs AK.
    Transpl Infect Dis; 2006 Mar 15; 8(1):3-12. PubMed ID: 16623815
    [Abstract] [Full Text] [Related]

  • 17. Renal allograft immunosuppression. III. Triple therapy versus three different combinations of double drug treatment: two year results in kidney transplant patients.
    Isoniemi H.
    Transpl Int; 1991 Apr 15; 4(1):31-7. PubMed ID: 2059298
    [Abstract] [Full Text] [Related]

  • 18. Long-term consequences of different immunosuppressive regimens for renal allografts.
    Isoniemi HM, Ahonen J, Tikkanen MJ, von Willebrand EO, Krogerus L, Eklund BH, Höckerstedt KV, Salmela KE, Häyry PJ.
    Transplantation; 1993 Mar 15; 55(3):494-9. PubMed ID: 8456467
    [Abstract] [Full Text] [Related]

  • 19. Conversion from cyclosporin to azathioprine 3 months after renal transplantation--is it safe?
    Cassidy MJ, Irving E, Swanepoel CR, Pascoe MD, van Zyl-Smit R, Jacobson JE.
    S Afr Med J; 1986 Sep 13; 70(6):317-8. PubMed ID: 3529454
    [Abstract] [Full Text] [Related]

  • 20. Protective effects of diltiazem and the prostazycline analogue iloprost in human renal transplantation.
    Neumayer HH, Kunzendorf U, Schreiber M.
    Ren Fail; 1992 Sep 13; 14(3):289-96. PubMed ID: 1380721
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.